Suchergebnisse - "Jiang, Yuqi"

PubPharm (10)

1

Structural understanding of 5-(4-hydroxy-phenyl)-N-(2-(5-methoxy-1H-indol-3-yl)-ethyl)-3-oxopentanamide as a neuroprotectant for Alzheimer's disease

enthalten in: Bioorganic & medicinal chemistry letters | 2021

von Saathoff, J. | Green, J. | Jiang, Y. | +3

2

Characterization and Discovery of a Selective Small-Molecule Modulator of Mitochondrial Complex I Targeting a Unique Binding Site

enthalten in: Journal of medicinal chemistry | 2020

von Green, J. | Jiang, Y. | He, L. | +9

3

Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia Activity

enthalten in: Journal of medicinal chemistry | 2020

von Li, X. | Jiang, Y. | Peterson, Y. | +9

4

Discovery of Second-Generation NLRP3 Inflammasome Inhibitors : Design, Synthesis, and Biological Characterization

enthalten in: Journal of medicinal chemistry | 2019

von Jiang, Y. | He, L. | Green, J. | +8

5

Development of bivalent compounds as potential neuroprotectants for Alzheimer's disease

enthalten in: Bioorganic & medicinal chemistry letters | 2019

von He, L. | Jiang, Y. | Green, J. | +2

6

Structural Insights of Benzenesulfonamide Analogues as NLRP3 Inflammasome Inhibitors : Design, Synthesis, and Biological Characterization

enthalten in: Journal of medicinal chemistry | 2018

von Fulp, J. | He, L. | Toldo, S. | +9

7

Design and characterization of bivalent compounds as potential neuroprotectants for Alzheimer's disease : Impact of the spacer on biological activity

enthalten in: Bioorganic & medicinal chemistry letters | 2018

von He, L. | Boice, A. | Liu, K. | +3

8

Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer's Disease

enthalten in: Journal of medicinal chemistry | 2018

von He, L. | Jiang, Y. | Liu, K. | +9

9

Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 Inflammasome Inhibitor for Potential Treatment of Multiple Sclerosis

enthalten in: ACS chemical neuroscience | 2017

von Guo, C. | Fulp, J. | Jiang, Y. | +5

10

Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activity

enthalten in: Journal of medicinal chemistry | 2014

von Li, X. | Inks, E. | Li, X. | +6

1
[1]